Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 25,000 | 0 | 0 | 0 |
| Gross Profit | N/A | 25,000 | N/A | N/A | N/A |
| Operating Expenses | 70,959 | 57,624 | 51,119 | 37,645 | 21,340 |
| Operating Income | -70,959 | -32,624 | -51,119 | -37,645 | -21,340 |
| Interest Expense | 0 | 4 | 4 | 1 | 0 |
| Other Income | 1,517 | 1,043 | 940 | 644 | -520 |
| Pre-tax Income | -69,442 | -31,585 | -50,183 | -37,002 | -21,860 |
| Net Income Continuous | -69,442 | -31,585 | -50,183 | -37,002 | -21,860 |
| Net Income | $-69,442 | $-31,585 | $-50,183 | $-37,002 | $-21,860 |
| EPS Basic Total Ops | -51.40 | -26.80 | -42.80 | -39.20 | -34.60 |
| EPS Basic Continuous Ops | -51.38 | -26.86 | -42.80 | -39.17 | -34.59 |
| EPS Diluted Total Ops | -51.40 | -26.80 | -42.80 | -39.20 | -34.60 |
| EPS Diluted Continuous Ops | -51.38 | -26.86 | -42.80 | -39.17 | -34.59 |
| EPS Diluted Before Non-Recurring Items | -15.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-70,431 | $-32,335 | $-50,759 | $-37,645 | $-21,340 |